Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Medical Study Establishes First-Ever Long-Term Benefits For Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
According to the World Health Organization (WHO), age-related macular degeneration (AMD) ranks third as a cause of visual impairment. It is the primary cause of visual impairment in industrial countries with a blindness prevalence of 8.7 percent. A new medical study indicates, however, that with the use of the Macular Health vitamin supplement there is a way to preserve the vision of millions of aging adults suffering from AMD.

Mouse Study Indicates Immune Cells From Spleen May Be Essential In Healing Heart Attack Damage
It takes a spleen to mend a broken heart - that"s the conclusion of a surprising new report from researchers at the Massachusetts General Hospital (MGH) Center for Systems Biology, directed by Ralph Weissleder, MD, PhD. In the July 31 issue of Science the team reports how, in following up an intriguing observation, they discovered an unexpected reservoir of the immune cells called monocytes in the spleen and went on to show that these cells are essential to recovery of cardiac tissue in an animal heart attack model.
News of the day
Researchers Gain Ground In Efforts To Fight Parasite Infection
New findings by researchers UT Southwestern Medical Center are accelerating efforts to eradicate worm infections that afflict a third of the world"s population.
Sexual Health

Common Antibiotics May Be Best First Treatment For Children With MRSA-related Infections

Penicillin and other antibiotics in the beta-lactam family work as well as other antibiotics to treat MRSA (methicillin-resistant Staphylococcuss aureus) infections in the skin and soft-tissue of children and may help prevent further resistance to antibiotic treatment, according to a new study funded by the Agency for Healthcare Research and Quality. The study, published in the June, 2009 issue of Pediatrics, compared treatment outcomes for three different antibiotics beta-lactums (which include penicillin, cephalosporins, carbapenems and monobactams), clindamycin, and trimethoprim-sulfamethoxazole (TMP -SMZ). The study concluded that children treated with clindamycin for skin and soft tissue infections potentially caused by MRSA did not show greater improvement compared to those treated with beta-lactam therapy. Children treated with TMP-SMZ were less likely to show improvement. Among the study"s findings: -- Beta- lactams may still be the best first line initial therapy for skin and soft tissue infections possibly caused by MRSA. -- Community- Acquired MRSA may not be the cause of skin and soft tissue infections even when MRSA is prevalent. -- The use of beta-lactams may help prevent further resistance to antibiotic treatment of skin and tissue infections. -- Beta-lactam therapy is more palatable to children than clindamycin because it is not associated with side effects, such as nausea and mild diarrhea. It is also not as expensive as other treatments. The authors of this study recommend further research to establish a higher level of evidence and to confirm study results. This study was funded by a cooperative agreement through an AHRQ grant to the Centers for Education and Research on Therapeutics (CERTs) research network, which is part of the agency"s Effective Health Care Program. The Effective Health Care Program sponsors the development of new scientific knowledge through studies on the outcomes of health care technologies and services. AHRQ


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009